Tags |
|
|
Links |
|
|
Useful Advices - Safety: Operator Training Program
When I was responsible for workplace safety training at a Westvaco p
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
lant, I developed operator training programs that not only included
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
the instructions on how to work safely but also, all the instruction
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
on how to do the job or operate the machine.
The resulting workpla
The resulting workpla
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ce safety instructions became a much used document instead of just t
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
e paper to look at before a safety audit. Or the one you pull out w
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
hen someone gets hurt.
By making the operator training program usef
By making the operator training program usef
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ul to the operators, they no longer dreaded the safety training and
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ctually paid attention. We based our safety and operator training p
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
rogram on the assumption that our operators wanted to do a good job
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
nd go home with the same number of fingers and toes that they arrive
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
d at the workplace with.
In the process safety documentation for ou
In the process safety documentation for ou
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
r distillation system, the safe operating limits for the system were
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
written right into the standard operating procedures. That way the
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
operators did not have to reference a separate document if they need
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
d to know how far they could push a process to compensate for some v
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ariable.
At the time we wrote these documents, this approach was co
At the time we wrote these documents, this approach was co
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
nsidered unorthodox and was hard to get it accepted by the first aud
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tors. Once people realized the value of this type of safety operato
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
r training program, our method become the model for others to follow
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/47039/usefuladvices-Safety-Operator-Training-Program.html">Safety: Operator Training Program</a>
BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/47039/usefuladvices-Safety-Operator-Training-Program.html]Safety: Operator Training Program[/url]
Related Articles:
Strategies for an Effective Job Search to Get You the Job or Career You Want
A Guide to Shopping for Business Credit Cards for New Business Owners
Bookmark it:
|